Theranostics Advances Aim to Personalize Cancer Treatment with AI and Biomarkers

Research into theranostics—combining diagnostics and therapy—is progressing, with new biomarkers, dosimetry, and AI integration under investigation to tailor cancer treatments. The scope of clinical adoption and efficacy remains uncertain, but the trend signals a shift toward more individualized oncology.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works